Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle weakness and degeneration. It primarily affects males, with symptoms typically appearing in early childhood. Diagnosing DMD involves a combination of clinical evaluations, genetic testing, and other diagnostic procedures.
The initial step in diagnosing DMD involves a thorough clinical evaluation by a healthcare professional. The doctor will review the patient's medical history, assess their symptoms, and perform a physical examination. During the examination, the doctor will look for signs of muscle weakness, such as difficulty in standing up, walking, or climbing stairs. They may also check for other associated symptoms like delayed motor milestones, enlarged calf muscles (pseudohypertrophy), and abnormal gait.
Since DMD is an inherited disorder, it is important to gather information about the patient's family history. The doctor will inquire about any family members who have been diagnosed with or have shown symptoms of muscular dystrophy. This information helps in assessing the likelihood of DMD and determining the appropriate diagnostic tests.
Genetic testing plays a crucial role in diagnosing DMD. The most common method used is DNA analysis to identify mutations in the dystrophin gene, which is responsible for producing the dystrophin protein. DMD is typically caused by a mutation or deletion in this gene. Genetic testing can be performed using a blood sample or a cheek swab. The sample is sent to a specialized laboratory where the DNA is analyzed to detect any abnormalities in the dystrophin gene.
In addition to genetic testing, enzyme testing is often conducted to measure the levels of creatine kinase (CK) in the blood. CK is an enzyme that leaks into the bloodstream when muscle fibers are damaged. In individuals with DMD, CK levels are significantly elevated. This test can provide further evidence of muscle damage and support the diagnosis of DMD.
In some cases, a muscle biopsy may be performed to confirm the diagnosis of DMD. During this procedure, a small piece of muscle tissue is surgically removed and examined under a microscope. The biopsy helps identify the absence or deficiency of dystrophin protein in the muscle fibers, which is a hallmark of DMD. However, muscle biopsy is less commonly used now due to the availability of genetic testing.
Electromyography (EMG) is a diagnostic procedure that measures the electrical activity of muscles. It involves inserting a fine needle electrode into the muscle to record its electrical signals. EMG can help assess the extent of muscle damage and distinguish between different types of muscular dystrophy. While it may not be necessary for every DMD diagnosis, it can provide valuable information in certain cases.
Additional tests may be recommended to evaluate the overall health and functioning of the patient. These can include:
Diagnosing Duchenne muscular dystrophy involves a combination of clinical evaluations, genetic testing, and other diagnostic procedures. The clinical evaluation helps identify characteristic symptoms and assess the patient's medical history. Genetic testing, primarily through DNA analysis, is crucial in detecting mutations or deletions in the dystrophin gene. Enzyme testing, such as measuring creatine kinase levels, can provide additional evidence of muscle damage. Muscle biopsy and electromyography may be used in specific cases to confirm the diagnosis or gather more information. Other tests, such as echocardiograms, pulmonary function tests, and imaging techniques, help evaluate associated complications and overall health. Early and accurate diagnosis of DMD is essential for appropriate management and intervention strategies.